Hospitals and healthcare systems need to be prepared to face scrutiny from the DEA and DOJ as they continue to enforce the Controlled Substances Act not only against illicit drug traffickers but also against legitimate healthcare providers. Over the past several years, a number of hospitals have entered into large settlements based on allegations that they failed to maintain adequate security and prevent the diversion of controlled substances, particularly opioids. These multi-million dollar settlements can include significant ongoing obligations, such as hiring an outside company to operate hospital pharmacies and retaining an auditor to verify controlled substance inventory counts.
Preventing controlled substance diversion is particularly challenging for hospitals because of the scale and complexity of their operations and the need for controlled substances to be readily accessible to staff members in patient care areas. Hospital systems should take a close look at their controlled substance diversion programs to ensure that potential diversion is being identified and addressed in a timely and effective manner.
King & Spalding has a wide range of experience with the DEA and the DOJ in the enforcement context as well as experience designing and implementing effective compliance programs. For this webinar, we have assembled a team of our compliance and enforcement experts to discuss practical ways to proactively evaluate and improve your organization’s controlled substance diversion prevention program. This webinar will focus on:
- Why hospitals are at risk of controlled substance diversion;
- What can trigger DEA scrutiny;
- Key elements of a controlled substance diversion prevention program in a hospital setting; and
- The questions to ask now to prepare your controlled substance diversion prevention program for government scrutiny.
If you have questions concerning this roundtable webinar, email Chayako Williams at firstname.lastname@example.org.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, email@example.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.